S Scholl
Impact in
- Cancer Research top 10%
- Breast Cancer Treatment Studies
-
- Breast Lesions and Carcinomas
Papers in
- Oncology 4
- HER2/EGFR in Cancer Research 2
- Cancer Risks and Factors 1
- Colorectal Cancer Screening and Detection 1
-
- Breast Cancer Treatment Studies 3
- Cancer Genomics and Diagnostics 1
- Co-authors
- Anne de la Rochefordière (4 shared papers)Philippe Broët (4 shared papers)P Pouillart (6 shared papers)Alain Fourquet (3 shared papers)Bernard Asselain (3 shared papers)Véronique Mosseri (2 shared papers)J. Durand (1 shared paper)Yann De Rycke (2 shared papers)
In The Last Decade
S Scholl
8 papers receiving 317 citations
Peers
Comparison fields: 5 of 38
- Cancer Research 212
- Pathology and Forensic Medicine 66
- Oncology 91
- Genetics 54
- Dermatology 16
Countries citing papers authored by S Scholl
This map shows the geographic impact of S Scholl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Scholl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Scholl more than expected).
Fields of papers citing papers by S Scholl
This network shows the impact of papers produced by S Scholl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Scholl. The network helps show where S Scholl may publish in the future.
Co-authors
The 22 scholars most cited alongside S Scholl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 151 | |
| 2 | 1999 | 97 | |
| 3 | 1996 | 29 | |
| 4 | 1999 | 26 | |
| 5 | [Herceptin, a monoclonal humanized antibody anti-HER2: a major therapeutic progress in breast cancers overexpressing this oncogene?]. | 1999 | 8 |
| 6 | Ifosfamide seven-day infusion for recurrent and cisplatin refractory ovarian cancer. | 1996 | 8 |
| 7 | [Vaccination against the tumoral mammary epithelial cells expressing MUC1 mucin]. | 1997 | 3 |
| 8 | 2015 | 2 |
About S Scholl
S Scholl is a scholar working on Oncology, Cancer Research, Radiology, Nuclear Medicine and Imaging, Molecular Biology and Pathology and Forensic Medicine, having authored 8 papers that have together received 324 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (3 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), HER2/EGFR in Cancer Research (2 papers), Cancer Genomics and Diagnostics (1 paper), Glycosylation and Glycoproteins Research (1 paper), Cancer Risks and Factors (1 paper), Gastric Cancer Management and Outcomes (1 paper) and Colorectal Cancer Screening and Detection (1 paper). The work is most often cited by research in Cancer Research (212 citations), Pathology and Forensic Medicine (66 citations), Oncology (91 citations), Genetics (54 citations) and Dermatology (16 citations). S Scholl has collaborated with scholars based in France and Germany. Frequent co-authors include Anne de la Rochefordière, Philippe Broët, P Pouillart, Alain Fourquet, Bernard Asselain, Véronique Mosseri, J. Durand, Yann De Rycke, Thierry Moreau and Emmanuelle Mouret‐Fourme. Their work appears in journals such as Breast Cancer Research and Treatment, Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics, Zeitschrift für Gastroenterologie and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.